Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC)

被引：15

作者：

Liu, Shiyi ^{[1
]}

Li, Saijiao ^{[2
]}

Wang, Yanqing ^{[1
]}

Wang, Feiyan ^{[1
]}

Zhang, Li ^{[1
]}

Xian, Shu ^{[1
]}

Yang, Dongyong ^{[1
]}

Yuan, Mengqin ^{[1
]}

Dai, Fangfang ^{[1
]}

Zhao, Xin ^{[1
]}

Liu, Yuping ^{[1
]}

Jin, Yumeng ^{[1
]}

Zeng, Zihang ^{[3
]}

Mahgoub, Omer Kamal Ahmed ^{[1
]}

Zhou, Chenliang ^{[4
]}

Cheng, Yanxiang ^{[1
]}

机构：

[1] Wuhan Univ, Renmin Hosp, Dept Obstet & Gynecol, JieFang Rd 238, Wuhan 430060, Hubei, Peoples R China

[2] Wuhan Univ, Renmin Hosp, Dept Reprod Med Ctr, Wuhan 430060, Hubei, Peoples R China

[3] Wuhan Univ, Zhongnan Hosp, Dept Tumor Ctr, Wuhan 430071, Hubei, Peoples R China

[4] Wuhan Univ, Renmin Hosp, Dept Crit Care Med Ctr, JieFang Rd 238, Wuhan 430060, Hubei, Peoples R China

来源：

JOURNAL OF CELLULAR BIOCHEMISTRY | 2020年 / 121卷 / 03期

关键词：

immunotherapy; mutation; prognosis; TCGA; tumor microenvironment; CANCER; THERAPY;

D O I：

10.1002/jcb.29479

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In this study, we attempted to evaluate the prognostic value of infiltrating immune/stromal cells in clear cell renal cell carcinoma (ccRCC), by using the immune scores and stromal scores based on the "Estimation of STromal and Immune cells in MAlignant Tumours using Expression data" algorithm to represent the levels of infiltrating immune cells and stromal cells. We found that the infiltrating immune cells were associated with poor prognosis of ccRCC. To assess the role of infiltrating immune cells in ccRCC cells, first, we performed differentially expressed genes analysis and functional analysis for validation. The results showed that the underlying mechanism by which infiltrating immune cells promoted cancer progression involved in regulating the nuclear division, angiogenesis, and immune response. Next, we investigated the relationship between infiltrating immune cells and mutations in ccRCC cells. We found that the infiltrating immune cells have certain effects on genetic mutations. In conclusion, infiltrating immune cells within the tumor microenvironment can be used to predict prognosis in ccRCC.

引用

页码：2571 / 2581

页数：11

共 29 条

[1] Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions
Atkins, M. B.
Clark, J. I.
Quinn, D. I.
[J]. ANNALS OF ONCOLOGY, 2017, 28 (07) : 1484 - 1494
[2] Treatment of renal cell carcinoma: Current status and future directions
Barata, Pedro C.
Rini, Brian I.
[J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) : 507 - 524
[3] The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells
Boyle, S. T.
Ingman, W. V.
Poltavets, V.
Faulkner, J. W.
Whitfield, R. J.
McColl, S. R.
Kochetkova, M.
[J]. ONCOGENE, 2016, 35 (01) : 105 - 115
[4] Bray F., 2018, CA Cancer J Clin, V66, P7
[5] Molecular Genetics of Clear-Cell Renal Cell Carcinoma
Brugarolas, James
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1968 - +
[6] Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis
Chaturvedi, Pallavi
Gilkes, Daniele M.
Wong, Carmen Chak Lui
Kshitiz
Luo, Weibo
Zhang, Huafeng
Wei, Hong
Takano, Naoharu
Schito, Luana
Levchenko, Andre
Semenza, Gregg L.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01) : 189 - 205
[7] An Immune Atlas of Clear Cell Renal Cell Carcinoma
Chevrier, Stephane
Levine, Jacob Harrison
Zanotelli, Vito Riccardo Tomaso
Silina, Karina
Schulz, Daniel
Bacac, Marina
Ries, Carola Hermine
Ailles, Laurie
Jewett, Michael Alexander Spencer
Moch, Holger
van den Broek, Maries
Beisel, Christian
Stadler, Michael Beda
Gedye, Craig
Reis, Bernhard
Pe'er, Dana
Bodenmiller, Bernd
[J]. CELL, 2017, 169 (04) : 736 - 749
[8] Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Choueiri, Toni K.
Halabi, Susan
Sanford, Ben L.
Hahn, Olwen
Michaelson, M. Dror
Walsh, Meghara K.
Feldman, Darren R.
Olencki, Thomas
Picus, Joel
Small, Eric J.
Dakhil, Shaker
George, Daniel J.
Morris, Michael J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06) : 591 - +
[9] The prospect of precision therapy for renal cell carcinoma
Ciccarese, Chiara
Brunelli, Matteo
Montironi, Rodolfo
Fiorentino, Michelangelo
Iacovelli, Roberto
Heng, Daniel
Tortora, Giampaolo
Massari, Francesco
[J]. CANCER TREATMENT REVIEWS, 2016, 49 : 37 - 44
[10] Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Eruslanov, Evgeniy B.
Bhojnagarwala, Pratik S.
Quatromoni, Jon G.
Stephen, Tom Li
Ranganathan, Anjana
Deshpande, Charuhas
Akimova, Tatiana
Vachani, Anil
Litzky, Leslie
Hancock, Wayne W.
Conejo-Garcia, Jose R.
Feldman, Michael
Albeida, Steven M.
Singhal, Sunil
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (12) : 5466 - 5480

← 1 2 3 →